- 39°08′14″N 77°13′36″W / 39.1371°N 77.2267°W / 39.1371; -77.2267
Novavax, Inc. is an
American biotechnology company based in Gaithersburg, Maryland...
- The
Novavax COVID-19 vaccine, sold
under the
brand names Nuvaxovid and Covovax,
among others, is a
subunit COVID-19
vaccine developed by
Novavax and the...
- Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin,
Novavax, Convidecia, and Sanofi–GSK.
Seven others are
under ****essment by the WHO:...
-
Serum Institute of
India also
reached an
agreement with
Novavax for the
production of
Novavax's NVX-CoV2373 (Covovax)
vaccine for
India and
other low and...
-
vaccines to
stimulate the
immune response. It was
patented in 2020 by
Novavax and is
composed of
nanoparticles from
saponins extracted from Quillaja...
- 2020.
Retrieved December 20, 2020. "
Novavax Announces $1.6
Billion Funding from
Operation Warp Speed".
Novavax. July 7, 2020.
Archived from the original...
- Indian-American
vaccinologist who
leads vaccine development at
Novavax. She
oversaw the
development of the
Novavax COVID-19 vaccine.
Patel was born in Sojitra, a farming...
- 1007/s12026-018-8991-x. PMC 5899102. "
Novavax COVID-19
Vaccine Demonstrates 89.3%
Efficacy in UK
Phase 3 Trial" (Press release).
Novavax. Jan 28, 2021. "Product Monograph:Arexvy"...
-
Therapeutic Goods (ARTG). As of 14 June 2021,
Novavax had
entered the
final stage of trials. As of 8 July 2021, the
Novavax COVID-19
vaccine was
under evaluation...
-
initially teamed with
Novavax Inc., a bio-technology
company also
based in Gaithersburg, MD., in the
development and
manufacture of the
Novavax COVID-19 vaccine...
